Clinical Trial Update: Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 study evaluating the PET radioligand [18F]MNI-815 for imaging tau in tauopathies has been completed, involving Alzheimer's disease, progressive su…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Corticobasal Degeneration
• Frontotemporal Dementia
• Progressive Supranuclear Palsy

Drugs mentioned

• [18F]MNI-815 (MNI-815)

Snippet

Sponsor: Molecular NeuroImaging | Conditions: Alzheimer's Disease (AD), Progressive Supranuclear Palsy (PSP) | EARLY_Phase 1 | Status: COMPLETED